HEIDI BOHLMANN: Open Payments
NPI 1457388464 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$433 in 20 payments from 10 companies in 2025. Trend: 2023 $500 · 2024 $911 · 2025 $433
Food & beverage: $433
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $106 |
| GlaxoSmithKline, LLC. | 3 | $76 |
| Amgen Inc. | 3 | $48 |
| Lilly USA, LLC | 2 | $44 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| PFIZER INC. | 2 | $32 |
| Noven Therapeutics, LLC | 1 | $25 |
| Astellas Pharma US Inc | 1 | $24 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| Exact Sciences Corporation | 1 | $20 |
Products named: TRELEGY ELLIPTA, Wegovy, ZEPBOUND, AIRSUPRA, OTEZLA, Xelstrym, Veozah, Ozempic.
Industry payments across CA — which companies pay providers there.
